Drug intelligence / Profile preview

Rezamid

Development stage: Unknown
Lead developer: Summers Laboratories
Modality: Small Molecules
Administration: Topical

Overview

Rezamid is an over-the-counter (OTC) topical acne treatment lotion developed and marketed by Summers Laboratories. It is a combination product containing 5% sulfur and 2% resorcinol. These active ingredients work synergistically to treat acne by providing keratolytic, drying, and antiseptic effects, which help to heal inflamed lesions such as pustules. A distinguishing feature of Rezamid is its Color Matcher™ liquid tint system, which allows users to customize the shade of the lotion to match their skin tone, providing concealment while treating the skin. It is marketed as a gentle alternative for patients who are sensitive or allergic to benzoyl peroxide and does not bleach fabrics.

Brand names: Rezamid

Targets

TPO (Thyroid peroxidase)

Beyond the preview

Go deeper on Rezamid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rezamid.

Explore the full profile